This article is a correction to fix a typographical error in the title of a previously published paper regarding the alpha-7 nicotinic acetylcholine receptor and heart failure.
Correction on: Swiderski J, Gadanec LK, Hearth S, Rowlands BD, Murphy AJ, Apostolopoulos V and Zulli A (2026) Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure. Front. Pharmacol. 17:1756039. doi: 10.3389/fphar.2026.1756039 Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failureThe title of this article was erroneously given as: sAlpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure.The correct title of the article is: Alpha-7 nicotinic acetylcholine receptor: targeting the interplay between inflammation, renin-angiotensin aldosterone system, and nervous system for the novel treatment of heart failure.There should be no "s" at the start of "Alpha-7 nicotinic…"
Swiderski et al. (Mon,) conducted a other in heart failure. This article is a correction to fix a typographical error in the title of a previously published paper regarding the alpha-7 nicotinic acetylcholine receptor and heart failure.